All news

Researchers at the University of Ottawa are unlocking new possibilities in next‑generation photonics, lab‑grown brain tissue and digitized history, backed by more than $17 million through the CFI’s Innovation Fund.

Polanyi Prize winner David Cook is driven by a simple but ambitious goal: to deepen our understanding of gynecologic diseases, develop new treatments, and improve prevention and early detection — particularly for ovarian cancer. He is dedicated to making a difference in women’s health.

The work of Dr. Julie St-Pierre’s lab suggests that forging fresh research insights into mitochondrial biology has strong potential to open new doors in cancer therapy.

New national health data platform gives researchers and institutions secure access to diverse types of health data to accelerate high-performance computing and innovation.

Clémence Metonnou, a nutritionist and public health researcher recognized for her strong commitment to improving health outcomes, has become the first woman from Benin to receive the prestigious BCDI 2030 scholarship. Implemented by a consortium led by Colleges and Institutes Canada and Universities Canada, and funded by Global Affairs Canada, the program aims to strengthen researchers’ profession...

The research landscape is changing fast. It is being shaped by open science, knowledge mobilization and partnerships with industries, communities and governments.

In a significant milestone on its path toward reconciliation with Indigenous Peoples, the University of Ottawa announced today the nomination of Elder Simon Brascoupé, a member of the Kitigan Zibi Anishinabeg First Nation whose career has been defined by a dedication to advancing Indigenous health through educational leadership, policy advocacy and community engagement, as Special Advisor to the D...

The International and Global Health Office (IGHO) offers a variety of student mobility options in France, Benin, China, and more. Discover how Marie-Yvette's international medical mobility experience enriched her educational journey below.

Dr. Jahani-Asl's team aims to translate compelling findings into targeted therapies and better outcomes for patients suffering from glioblastoma.

Dr. LeBlanc received the competitive recognition for her significant contributions to medical education research, policy and practice.